About us
Founded in the early spring of 2024, VitaNova Venture Capital derives its name from the fusion of two Latin words: 'Vita,' meaning life, and 'Nova,' signifying new beginnings. Our ethos is deeply rooted in forward thinking, dedicated to championing emerging, fresh, and transformative innovation ideas underpinned by robust technical foundations. Committed to the long-term success of these ventures, we aspire to cultivate and propel them into the limelight, shaping the future of human life.
While VitaNova embodies the spirit of 'nova,' it traces its roots to its predecessor, Jiasheng Capital, renowned for its focus on investment opportunities across primary and secondary markets. With a track record of over 30 investments, boasting more than 10 successful exits and a portfolio that includes over 10 ventures that have gone public, Jiasheng Capital laid the groundwork for VitaNova's evolution. VitaNova inherits the professional management team and distinctive investing strategy from Jiasheng Capital, while forging its own path by concentrating primarily on early-stage, technology-driven startups poised to redefine our future.
We invest in
Technology driven
startups
Angel, seed,
pre-A and A round
Life science, AI, Robotics,
New materials
Better human life and
better future
Our Advantages
Light speed
fast decision making and fast closing
Professional
strong technical, financial, and operational expertise
Supportive
we grow together with our ventures
Long-term
we care about the value and impact in long term
Our Investment

NIO: When technology and design meets electric car.

NYSE: NIO, 2018

KE Holdings: Provide comprehensive and trusted housing services to more than 300 million families.

NYSE: BEKE, 2020

Giant Biogene: Researches, develops, manufactures, and distributes, and markets skin treatment products, especially recombinent collagen.

HKEX: 02367, 2022

Genetron: Full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care.

NASDAQ: GTH, 2020

Syntiant: A deep learning tech company providing AI voice and sensor solutions.

Smartbeam: Deeply rooted in the development of key technologies for CT tube products.

JD Logistics: The delivery arm of the Chinese e-commerce giant JD.

HKEX: 02618, 2021

Combinati: Owns cutting-edge dPCR technology to rapidly develop and commercialize it alongside an expanding portfolio of assays.

Acquired by Thermal Fisher Scientific, 2021

Titan: Provides laboratory products and services for scientific research information researchers.

SSE: 688133, 2020

Trueland: Provides a SaaS intelligent marketing cloud platform and management platform.

Seatrec: A climatetech/bluetech startup creating solutions for clean, sustainable energy production from temperature differences in the ocean.

Agene: Committed to the application of ultra-sensitive genetic testing technologies, such as mNGS (metagenomic Next Generation Sequencing) and multiplex PCR, in clinical setting.

ZuriMed: Zurich based innovative orthopedics solutions